Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Meningeal Carcinomatosis 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 59fludarabine phosphate 42Peripheral Blood Stem Cell Transplantation 33Cyclosporine 32Busulfan 32Radiotherapy 30Mycophenolic Acid 30Filgrastim 30Antilymphocyte Serum 28Whole-Body Irradiation 26Melphalan 21Methylprednisolone 19Methotrexate 19Etoposide 19Tacrolimus 17Cord Blood Stem Cell Transplantation 17Cytarabine 10Thiotepa 9fludarabine 6aldesleukin 6sargramostim 5Vincristine 5Sirolimus 5Rituximab 5Psychiatric Rehabilitation 5Granulocyte Colony-Stimulating Factor 5Therapeutics 4Prednisone 4Doxorubicin 4Carboplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dendritic Cell Sarcoma, Interdigitating × trioctyl phosphine oxide × Other hematologic neoplasm × Clear all
NCT00005811 2013-02-21

Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment

National Cancer Institute (NCI)

Phase 2 Completed
77 enrolled
CNSLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Medulloblastoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡